Additionally, exosomes can target novel tumor-associated antigens such as B7-H3, highly expressed in different tumors, or loaded with immune-stimulatory molecules, such as IL-5 or perforin, to enhance NK cytotoxicity and promote a more robust immune response within the TME. The gene discussed is CD276; the disease is neoplasm.